Whittier Trust’s Trinity Biotech TRIB Stock Holding History

Whittier Trust’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$4K	–	1376
2018 Q3	$4K	Hold	200	–	–	﹤0.01%	1144
2018 Q2	$5K	Hold	200	–	–	﹤0.01%	1106
2018 Q1	$5K	Hold	200	–	–	﹤0.01%	1144
2017 Q4	$5K	Hold	200	–	–	﹤0.01%	1129
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	1118
2017 Q2	$6K	Hold	200	–	–	﹤0.01%	1078
2017 Q1	$6K	Hold	200	–	–	﹤0.01%	1120
2016 Q4	$7K	Hold	200	–	–	﹤0.01%	1013
2016 Q3	$13K	Hold	200	–	–	﹤0.01%	937
2016 Q2	$11K	Hold	200	–	–	﹤0.01%	977
2016 Q1	$12K	Hold	200	–	–	﹤0.01%	949
2015 Q4	$12K	Hold	200	–	–	﹤0.01%	940
2015 Q3	$11K	Hold	200	–	–	﹤0.01%	951
2015 Q2	$18K	Buy	+200	New	+$17.3K	﹤0.01%	921

Other funds holding TRIB

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Whittier Trust's TRIB Position: Q4 2018 in Review

Whittier Trust sold out of Trinity Biotech (TRIB) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Whittier Trust first reported a position in TRIB in Q2 2015 and held it in 14 quarters. The position peaked at $18K in Q2 2015. 41 funds tracked by Wall St. Rank hold TRIB as of Q4 2018.

Whittier Trust reported no remaining Trinity Biotech position as of Q4 2018 after selling out during the quarter.
Whittier Trust sold 200 Trinity Biotech shares in Q4 2018, an estimated $4K.
Whittier Trust first reported a position in Trinity Biotech in Q2 2015 and held it in 14 quarters.
Whittier Trust's Trinity Biotech position peaked at $18K in Q2 2015.
41 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2018.

Based on Whittier Trust's 13F filing for Q4 2018, filed 7 Feb 2019.